6.18
price up icon3.34%   0.20
after-market Dopo l'orario di chiusura: 2.66 -3.52 -56.96%
loading

Gt Biopharma Inc Azioni (GTBP) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Selling, General, and Administrative
53.53%
4.219
2.748 1.15 0.833 2.297
Operating Income/Loss
65.43%
-5.595
-3.382 -1.513 -1.932 -3.604
Nonoperating Income/Loss
100.97%
-0.113
11.68 -28.66 1.156 0.193
Income/Loss From Continuing Operations Before Tax
168.78%
-5.708
8.299 -30.17 -0.80 -3.411
Income/Loss From Continuing Operations After Tax
168.78%
-5.708
8.299 -30.17 -0.80 -3.411
Net Income/Loss
168.78%
-5.708
8.299 -30.17 -0.80 -3.411
Preferred Stock Dividends And Other Adjustments
56.97%
1.808
4.202 0.085 - -
Attributable To Noncontrolling Interest
-
- - -0.024 -
Basic Average Shares
36.86%
2.4882
3.9407 2.7718 2.3451 2.2343
Diluted Average Shares
36.86%
2.4882
3.9407 2.7718 2.3451 2.2343
Basic Earnings Per Share
113.46%
2.22
1.04 -10.92 -0.33 -1.53
Diluted Earnings Per Share
113.46%
2.22
1.04 -10.92 -0.33 -1.53
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
56.97%
1.808
4.202 0.085 - -
$58.75
price down icon 3.04%
$127.28
price down icon 1.18%
$40.94
price down icon 2.08%
$247.51
price down icon 4.07%
ONC ONC
$341.80
price down icon 2.62%
$203.35
price down icon 2.08%
Capitalizzazione:     |  Volume (24 ore):